Boston, June 2025. It wasn’t just another industry event. BIO International 2025 was a pivotal moment for Nanofacile.
As part of Québec’s delegation of over 100 biotech leaders, we joined the global life sciences community for a week of high stakes conversations, bold ideas, and real momentum. And one thing was clear: RNA therapeutics are no longer the future, they’re happening now. Fast.
Why We Came
Nanofacile’s mission is simple but ambitious: make RNA delivery faster, simpler, and more scalable. BIO 2025 gave us the ideal platform to showcase Nanomedicine in a Box, our plug and play LNP development platform, to the people who need it most, from emerging startups to established pharmaceutical players.
In just a few days, we were able to:
Validate our technology with key players in RNA therapeutics
Open promising discussions with international partners
Explore new opportunities for global collaboration in lipid nanoparticle (LNP) development
More Than a Booth
The Québec pavilion wasn’t just a presence, it was a force. The energy, alignment, and drive for impact among the delegation stood out. What we saw in Boston wasn’t just interest in innovation; it was demand for solutions that can scale.
Every conversation we had reinforced our belief: speed and simplicity in RNA delivery are no longer optional, they’re critical.
What’s Next
BIO 2025 confirmed that Nanofacile is in the right place, at the right time and with the right technology. We're heading back to Montreal with:
New leads across North America and Europe
Concrete next steps with strategic partners
A sharper sense of where the RNA space is going and how we can lead the way
This is only the beginning. The conversations that started at BIO are already turning into action. And for Nanofacile, that’s exactly the point.